StockNews.com Initiates Coverage on Can-Fite BioPharma (NYSE:CANF)
StockNews.com assumed coverage on shares of Can-Fite BioPharma (NYSE:CANF – Free Report) in a report published on Friday morning. The brokerage issued a hold rating on the stock. Other equities research analysts have also recently issued reports about the stock. EF Hutton Acquisition Co. I raised shares of Can-Fite BioPharma to a strong-buy rating in […]
More Stories
Synthetix Price Tops $1.46 on Top Exchanges (SNX)
Synthetix (SNX) traded 2.9% lower against the dollar during the one day period ending at 0:00 AM E.T. on October...
Symbol (XYM) Price Up 0.4% Over Last 7 Days
Symbol (XYM) traded up 0.9% against the U.S. dollar during the 24 hour period ending at 0:00 AM Eastern on...
SPX Technologies (NYSE:SPXC) Issues FY 2024 Earnings Guidance
SPX Technologies (NYSE:SPXC – Get Free Report) issued an update on its FY 2024 earnings guidance on Wednesday morning. The...
Manhattan Scientifics, Inc. (OTCMKTS:MHTX) Short Interest Down 18.1% in October
Manhattan Scientifics, Inc. (OTCMKTS:MHTX – Get Free Report) was the target of a significant decline in short interest during the...
Governance OHM Self Reported Market Capitalization Tops $196.16 Million (GOHM)
Governance OHM (GOHM) traded down 0.4% against the U.S. dollar during the 24-hour period ending at 0:00 AM Eastern on...
Coin98 (C98) One Day Trading Volume Tops $8.65 Million
Coin98 (C98) traded 0.7% lower against the dollar during the 1 day period ending at 0:00 AM E.T. on October...